Sebastian Giebel

Research interests

Publications

• Diagnosis, prognostic factors, and assessment of ALL in adults: 2024 ELN recommendations from a European expert panel

  Blood · 2024 · https://doi.org/10.1182/blood.2023020794

• Management of ALL in adults: 2024 ELN recommendations from a European expert panel

  Blood · 2024 · https://doi.org/10.1182/blood.2023023568

• Prophylaxis and management of graft-versus-host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation

  The Lancet Haematology · 2024 · https://doi.org/10.1016/s2352-3026(23)00342-3

• Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease

  New England Journal of Medicine · 2021 · https://doi.org/10.1056/nejmoa2033122

• Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation

  The Lancet Haematology · 2020 · https://doi.org/10.1016/s2352-3026(19)30256-x

• Management of patients with acute leukemia during the COVID-19 outbreak: practical guidelines from the acute leukemia working party of the European Society for Blood and Marrow Transplantation

  Bone Marrow Transplantation · 2020 · https://doi.org/10.1038/s41409-020-0970-x

• Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patients

  Bone Marrow Transplantation · 2020 · https://doi.org/10.1038/s41409-020-0803-y

• Hematopoietic stem cell transplantation for adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first remission: a position statement of the European Working Group for Adult Acute Lymphoblastic Leukemia (EWALL) and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

  Bone Marrow Transplantation · 2018 · https://doi.org/10.1038/s41409-018-0373-4

• Evolution, trends, outcomes, and economics of hematopoietic stem cell transplantation in severe autoimmune diseases

  Blood Advances · 2017 · https://doi.org/10.1182/bloodadvances.2017010041

• International reference analysis of outcomes in adults with B-precursor Ph-negative relapsed/refractory acute lymphoblastic leukemia

  Haematologica · 2016 · https://doi.org/10.3324/haematol.2016.144311

• Use of tyrosine kinase inhibitors to prevent relapse after allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome–positive acute lymphoblastic leukemia: A position statement of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

  Cancer · 2016 · https://doi.org/10.1002/cncr.30130

• Relapse of AML after hematopoietic stem cell transplantation: methods of monitoring and preventive strategies. A review from the ALWP of the EBMT

  Bone Marrow Transplantation · 2016 · https://doi.org/10.1038/bmt.2016.167

• Blinatumomab vs historical standard therapy of adult relapsed/refractory acute lymphoblastic leukemia

  Blood Cancer Journal · 2016 · https://doi.org/10.1038/bcj.2016.84

• Cladribine, But Not Fludarabine, Added to Daunorubicin and Cytarabine During Induction Prolongs Survival of Patients With Acute Myeloid Leukemia: A Multicenter, Randomized Phase III Study

  Journal of Clinical Oncology · 2012 · https://doi.org/10.1200/jco.2011.37.1286

• Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors

  Blood · 2003 · https://doi.org/10.1182/blood-2003-01-0091

Current projects

No projects listed.